Ourania Tsitsilonis - Concepedia

Author

Ourania Tsitsilonis

National and Kapodistrian University of Athens ORCID

Also Known As

Ioannis V. Kostopoulos, O E Tsitsilonis, O Tsitsilonis, O. E. Tsitsilonis, O. Tsitsilonis, O.E. Tsitsilonis, OURANIA E. TSITSILONIS, Ourania E Tsitsilonis, Ourania E. Tsitsilonis, Ourania Tsitsilonis

254

Publications

3.6K

Citations

H-Index

110

Concepts

All Affiliations

National and Kapodistrian University of Athens Alexandra Hospital University of Tübingen St Savas Hospital Biomedical Research Foundation of the Academy of Athens

About

Ourania Tsitsilonis is an author at National and Kapodistrian University of Athens specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	32	1.3K
2	Health Sciences	4	4	100
3	Allergy	3	3	82
4	Natural Sciences	2	2	61
5	Social Sciences	1	1	23

Ourania Tsitsilonis

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals <i>via</i> VEGF receptor Type 2 Apostolos C Ziogas, Nikos G. Gavalas, Marinos Tsiatas, International Journal of Cancer Healthy IndividualsT-regulatory CellImmunologyVegf ReceptorT Cells	2011	162
VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2 N. Gavalas, Marinos Tsiatas, Ourania Tsitsilonis, British Journal of Cancer	2012	161
Tumor-Specific CD4+ T Lymphocytes from Cancer Patients Are Required for Optimal Induction of Cytotoxic T Cells Against the Autologous Tumor Constantin N. Baxevanis, Ioannis F. Voutsas, Ourania Tsitsilonis, The Journal of Immunology T-regulatory CellImmunologyAutologous TumorImmunologic MechanismCancer Patients	2000	161
Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFα in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy Aristotelis Bamias, Vasiliki Koutsoukou, Evangelos Terpos, Gynecologic Oncology Platinum ResistanceCancer ImmunosurveillanceMalignant DiseaseMedicineImmunology	2007	92
Compromised anti-tumor responses in tumor necrosis factor-α knockout mice Constantin N. Baxevanis, Ioannis F. Voutsas, Ourania Tsitsilonis, European Journal of Immunology InflammationCancer ImmunosurveillanceAutoimmune DiseaseAnti-tumor ResponsesImmune Regulation	2000	79
Oxidative stress-mediated biomolecular damage and inflammation in tumorigenesis. Fabiola Sesti, Ourania Tsitsilonis, Athanassios Kotsinas, PubMed InflammationOncogenic AgentMedicineInducible Antioxidant ProgramPathology	2012	78
Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance Aristotelis Bamias, Marinos Tsiatas, Eftychia Kafantari, Gynecologic Oncology Hematological MalignancyPlatinum ResistanceTumoral PathologyMedicineImmunology	2007	76
Selective cytotoxicity of the herbal substance acteoside against tumor cells and its mechanistic insights Christina Cheimonidi, Pinelopi Samara, Panagiotis Polychronopoulos, Redox Biology ImmunologyPathologySelective CytotoxicityTumor CellsActeoside Inhibits	2018	64
Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone Efstathios Kastritis, Ioanna Dialoupi, Maria Gavriatopoulou, Blood Advances	2019	53
Development and immunochemical evaluation of antibodies Y for the poorly immunogenic polypeptide prothymosin alpha Persefoni Klimentzou, Maria Paravatou‐Petsotas, Christos Zikos, Peptides AllergyAutoimmune DiseaseMedicinePathogenesisImmunology	2005	43

Page 1